Press Releases, News, and Events
ChromaCode making an impact

CARLSBAD, Calif., Aug. 10, 2023 /PRNewswire/ — ChromaCode, Inc., a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients, and physicians, today announced a strategic partnership with Protean BioDiagnostics Inc., a CAP/CLIA-accredited, high-complexity laboratory specializing in developing

CARLSBAD, Calif. July 11, 2023 /PRNewswire/ — ChromaCode, Inc., a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, today announced an early-access commercial launch of a non-small-cell lung cancer assay based on innovative High Definition

CARLSBAD, Calif., April 27, 2023 – ChromaCode, Inc., a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, announced today a partnership with MedGenome, to bring its innovative High Definition PCR (HDPCR™) multiplexing technology to

CARLSBAD, Calif. – November 1, 2022 – ChromaCode, Inc., which brings accessible and affordable insights to labs, patients and physicians through its innovative High Definition PCR (HDPCRTM) multiplexing solution, announced today that it will present its HDPCR oncology data, studied

Over six million tests have been performed and analyzed using the HDPCR™ SARS-CoV-2 EUA assay and ChromaCode Cloud™ CARLSBAD, Calif. – February 23, 2022 – ChromaCode, Inc., a company redefining molecular testing through data science, announced today that the U.S. Food and